Cardiovascular Surgery Department, Luigi Sacco University General Hospital, Milano, Italy.
J Thorac Cardiovasc Surg. 2012 Mar;143(3):625-31. doi: 10.1016/j.jtcvs.2011.11.011. Epub 2011 Dec 10.
To analyze the risk reduction of cardiopulmonary bypass complications between on-pump and off-pump coronary artery bypass grafting in high-risk patients.
This multicenter, prospective, randomized, parallel trial enrolled patients for elective or urgent isolated coronary artery bypass grafting with an additive European System for Cardiac Operative Risk Evaluation of 6 or more. The patients in cardiogenic shock were excluded. The composite primary end point included operative mortality, myocardial infarction, stroke, renal failure, reoperation for bleeding and adult respiratory distress syndrome within 30 days after surgery. The total sample size was 693 patients, according to a scheduled interim analysis at 400 patients enrolled (α-spending = 0.029, Pocock method).
A total of 411 patients were included in the interim analysis. Randomization assigned 203 patients to on-pump and 208 patients to off-pump treatment. Of the 411 patients, 24 crossed over; thus, 195 patients were actually treated on-pump and 216 off-pump. According to the intention to treat analysis, the rate of the composite primary end point was significantly lower (unadjusted P = .009, adjusted P = .010) in the off-pump group (5.8% vs 13.3%). The risk of experiencing the primary end point was significantly greater for the on-pump group (unadjusted odds ratio, 2.51; 95% confidence interval, 1.23-5.10; P = .011; adjusted odds ratio, 3.07; 95% confidence interval, 1.32-7.14; P = .009).
Off-pump coronary artery bypass grafting reduces early mortality and morbidity in high-risk patients.
分析高危患者中体外循环与非体外循环冠状动脉旁路移植术的心肺旁路并发症风险降低情况。
本多中心、前瞻性、随机、平行试验纳入了择期或紧急行单纯冠状动脉旁路移植术的患者,附加欧洲心脏手术风险评估系统评分 6 分或以上。排除心源性休克患者。复合主要终点包括术后 30 天内的手术死亡率、心肌梗死、卒、肾衰竭、再出血和成人呼吸窘迫综合征。根据 400 例患者入组时的预定中期分析(α花费=0.029,Pocock 法),总样本量为 693 例。
共有 411 例患者进行了中期分析。随机分为 203 例患者行体外循环和 208 例患者行非体外循环治疗。411 例患者中,有 24 例患者交叉,因此,195 例患者实际接受体外循环治疗,216 例患者接受非体外循环治疗。根据意向治疗分析,非体外循环组的复合主要终点发生率显著较低(未校正 P=0.009,校正 P=0.010)。体外循环组发生主要终点的风险显著更高(未校正优势比,2.51;95%置信区间,1.23-5.10;P=0.011;校正优势比,3.07;95%置信区间,1.32-7.14;P=0.009)。
非体外循环冠状动脉旁路移植术降低了高危患者的早期死亡率和发病率。